血液透析施行中のゲノタイプ1のC型慢性肝炎・代償性肝硬変患者に対するグレカプレビル・ピブレンタスビル併用療法の有効性と安全性 : KTK49 Liver Study Group
Digital data available（Japan Link Center）
Begin reading now
CiNii Research
Holdings of Libraries in Japan
This page shows libraries in Japan other than the National Diet Library that hold the material.
Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.
other
CiNii Research
Search ServiceDigitalYou can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 記事
- Author/Editor
- 厚川 正則近藤 千紗中牟田 誠豊田 秀徳熊田 卓高口 浩一渡邊 綱正池田 裕喜道堯 浩二郎平岡 淳朝井 章福西 新弥島田 紀朋三上 繁魚嶋 晴紀玄田 拓哉安部 宏加藤 慶三小川 力池上 正坪田 昭人淺野 徹野﨑 昭人新井 泰央糸川 典夫飯尾 悦子田中 靖人岩切 勝彦
- Author Heading
- Alternative Title
- Efficacy and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Genotype 1b Chronic Hepatitis C Patients with and without Cirrhosis Undergoing Hemodialysis
- Periodical title
- 肝臓
- No. or year of volume/issue
- 59(10):2018.10
- Volume
- 59
- Issue
- 10
- Pages
- 578-580